PF-AtlasКлинические испытания › NCT07612865

People's Hospital of Xinjiang Uygur Autonomous Region

ERAS group · Не указано

ID реестра
NCT07612865
Фаза
Не указано
Статус
Завершено
Препарат / вмешательство
ERAS group
Спонсор
People's Hospital of Xinjiang Uygur Autonomous Region
Начало
2022-09-05
Набор участников
160
Центры
1

Об исследовании

Objective: To evaluate the impact of enhanced recovery after surgery (ERAS)-based nursing intervention on venous thromboembolism (VTE) and lymphedema after radical hysterectomy for cervical cancer. Methods: In this prospective randomized controlled trial, 160 patients scheduled for radical hysterectomy during September 2022-September 2024 were randomized to an ERAS group (n = 80) or a control group (n = 80). The control group received conventional perioperative care, while the ERAS group received a multimodal perioperative care protocol. Primary outcomes were the 6-month incidence of VTE and lower limb lymphedema. Secondary outcomes included recovery indicators, inflammatory and coagulation markers, quality of life \[QoL; assessed by the Quality of Life Questionnaire-Core 30 (QLQ-C30)\], and nursing satisfaction.

Открыть NCT07612865 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT07612865 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.